Pharmacology News and Research

Latest Pharmacology News and Research

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

Should pregnant women be included clinical trials?

Should pregnant women be included clinical trials?

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

Turning to Organ-on-a-Chip Studies for the Future of Drug Discovery

Turning to Organ-on-a-Chip Studies for the Future of Drug Discovery

NUS study provides evidence of the cytotoxic effect of black cardamom on lung cancer cells

NUS study provides evidence of the cytotoxic effect of black cardamom on lung cancer cells

Two Weill Cornell doctoral students receive Gilliam Fellowships for Advanced Study from HHMI

Two Weill Cornell doctoral students receive Gilliam Fellowships for Advanced Study from HHMI

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

Lactating mice expose their feeding pups to triclosan resulting in early signs of liver damage

Lactating mice expose their feeding pups to triclosan resulting in early signs of liver damage

Genetic variations in one serotonin receptor could be the reason behind psychedelic treatment disparity

Genetic variations in one serotonin receptor could be the reason behind psychedelic treatment disparity

Researchers unravel how one gut bacterium influences immunity

Researchers unravel how one gut bacterium influences immunity

UTHSC investigators secure $2.16 million to test a new way to combat neurodegenerative disorders

UTHSC investigators secure $2.16 million to test a new way to combat neurodegenerative disorders

Scientists find new evidence against using BET inhibitors to treat COVID-19

Scientists find new evidence against using BET inhibitors to treat COVID-19

Men with hematopoietic mosaic loss of Y chromosome have worse prognosis for heart failure

Men with hematopoietic mosaic loss of Y chromosome have worse prognosis for heart failure

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

Y chromosome loss in men can lead to deadly heart failure, research shows

Y chromosome loss in men can lead to deadly heart failure, research shows

New transport system exemplifies the potential of a de novo design of peptides and proteins

New transport system exemplifies the potential of a de novo design of peptides and proteins

Study describes biochemical pathway that leads to inflammation characteristic of autoimmune diseases

Study describes biochemical pathway that leads to inflammation characteristic of autoimmune diseases

Mount Sinai receives $4.2 million to establish a Proteogenomic Data Analysis Center

Mount Sinai receives $4.2 million to establish a Proteogenomic Data Analysis Center

How common is pediatric cannabis use and what are the risks?

How common is pediatric cannabis use and what are the risks?

Researchers challenge centuries-old beliefs about limb regeneration

Researchers challenge centuries-old beliefs about limb regeneration

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.